A verification study to evaluate the safety of continuous consumption of Enterococcus faecium WB2000: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study to evaluate the safety of continuous consumption of Enterococcus faecium WB2000

ORTHOMEDICO Inc.0 个研究点目标入组 22 人开始时间: 2024年3月1日最近更新: 2024年9月2日

试验速览

暂无简介。

•1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses," "Foods with Functional Claims," or "Foods with Nutrient Function Claims" 5. Individuals who are taking/using medications (including herbal medicines), internal quasi-drugs, and supplements 6. Individuals who are allergic to medicines and/or the test food related products 7. Individuals who are pregnant, lactating, or planning to become pregnant during this study 8. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate another study during this study 9. Individuals who are judged as ineligible to participate in this study by the physician

发起方